# A Study of Sotatercept in Japanese Pulmonary Arterial Hypertension (PAH) Participants (MK-7962-020)

> **NCT05818137** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 46 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **BIOLOGICAL:** Sotatercept

## Key facts

- **NCT ID:** NCT05818137
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-10
- **Primary completion:** 2024-03-12
- **Final completion:** 2025-11-06
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05818137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05818137, "A Study of Sotatercept in Japanese Pulmonary Arterial Hypertension (PAH) Participants (MK-7962-020)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05818137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*